1434 - STATIC TRIAL (Stopping Therapy to Avoid Treatment-resistance In CLL): A randomised phase III trial comparing intermittent with continuous treatment strategies in CLL

Primary Author / Presenter(s)

Talha Munir, MBBS, MRCP, FRCPath, PhD

Consultant Haematologist
Leeds Teaching Hospitals NHS Trust
Leeds, England, United Kingdom

DC

David Cairns, PhD

Leeds CRUK CTU, Leeds Institute of Clinical Trials Research, University of Leeds, United Kingdom
NG

Natasha Greatorex, BSc

University of Leeds
Leeds, England, United Kingdom
RL

Rhiannon Lambkin, BSc

University of Leeds
Leeds, England, United Kingdom
SJ

Sharon Jackson, PhD

University of Leeds
Leeds, England, United Kingdom
AM

Annah Muli, MSc

University of Leeds
Leeds, England, United Kingdom
DE

Dax Everritt, BSc

University of Leeds
Leeds, England, United Kingdom
CS

Colleen Sellwood, MSc

University of Leeds
Leeds, England, United Kingdom
AR

Andy Rawstron, PhD

Leeds Teaching Hospitals NHS Trust
Leeds, England, United Kingdom
BD

Bryony Dawkins, MSc

University of Leeds
Leeds, England, United Kingdom
DA

David Allsup, MD, Phd

Department Hematology, Hull University Teaching Hospitals NHS Trust
Hull, England, United Kingdom
AB

Adrian Bloor, MA, MB, Bchir, PhD, FRCP, FRCPath

Christie Hospital NHS Trust
Manchester, England, United Kingdom
LD

Lelia Duley

CLL Support Association
Nottingham, England, United Kingdom
HL

Hilary Lindsay

CLL support Association, UK
London, England, United Kingdom